⌘K

Login Start Free

Home/Filings/4/0001062993-18-002795

4//SEC Filing

Caplan Vered 4

Accession 0001062993-18-002795

CIK 0001460602other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 4:28 PM ET

Size

5.4 KB

Accession

0001062993-18-002795

Insider Transaction Report

Form 4

Period: 2018-06-28

Orgenesis Inc.ORGS

Director

Transactions

Award
Stock Option (Right to Buy Common Stock)
2018-06-28+250,000→ 250,000 total
Exercise: $8.36From: 2018-12-28Exp: 2028-06-28→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]The options were awarded under the Issuer's 2017 Equity Incentive Plan and are scheduled to vest in two equal installments of 125,000 option shares on each of December 28, 2018 and June 28, 2019 and are exercisable at a per share exercise price of $8.36.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Orgenesis Inc.

CIK 0001460602

Entity typeother

Related Parties

1

filerCIK 0001298525

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 4:28 PM ET
Size: 5.4 KB

View on SEC.gov